Top section
Top section
Investors have lots of cash and are eager for new issuance
Investors are keen for new bonds and better rated borrowers may not want to issue in numbers
2026's lead in issuance over 2025 has shrunk since the US-Iran war broke out
Data
More articles
More articles
More articles
-
Genscript Biotech Corp, a leading life sciences service provider and drug developer, has raised HK$2.39bn ($304m) after upsizing a follow-on offering, according to a source close to the deal. -
Hyundai Capital America took advantage of investors’ newfound love of floating rate notes on Monday, sealing a $1.3bn triple-tranche deal led by a three year floater.
-
China-based VCredit Holdings, which provides online consumer finance, launched bookbuilding for its IPO on Tuesday, with proceeds of up to HK$1.58bn ($201m) in reach.
-
A joint notice by three Chinese government regulatory bodies limiting new capacity in solar power generation has caused several offshore renewable energy bonds to tank in the secondary market.
-
Less than two years after it completed a restructuring in which all of its existing debt was wiped out, Frontera Energy is plotting a return to primary bond markets.
-
A decision by the new prime minister of Barbados to suspend all external debt payments sent the island’s bond prices down more than 50 points, stunning bondholders who were mostly not expecting to take the brunt of a long-term economic decline.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
